BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 103 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $289,000 | +3.6% | 6,601 | +21.9% | 0.00% | 0.0% |
Q1 2019 | $279,000 | -54.3% | 5,414 | -66.7% | 0.00% | -50.0% |
Q3 2018 | $610,000 | -6.0% | 16,240 | -1.1% | 0.00% | 0.0% |
Q2 2018 | $649,000 | +84.4% | 16,420 | +20.1% | 0.00% | +100.0% |
Q1 2018 | $352,000 | – | 13,677 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 710,422 | $24,658,747 | 16.62% |
Birchview Capital, LP | 7,365 | $255,639 | 0.24% |
Itau Unibanco Holding S.A. | 88 | $3,054 | 0.00% |